Bartonella infection: Treatment and drug resistance

Future Microbiology

Volumn 5, Issue 11, 2010, Pages 1719-1731

  Biswas, Silpak ^a   Rolain, Jean Marc ^a  

^a CNRS   (France)

Author keywords

antibiotic resistance; antibiotic susceptibility; Bartonellosis; Etest assay; in vitro mutants

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ENROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; OFLOXACIN; PENICILLIN G; PLACEBO; PRADOFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACILLARY ANGIOMATOSIS; BACTERIAL ENDOCARDITIS; BARTONELLA; BARTONELLA BACILLIFORMIS; BARTONELLA ENDOCARDITIS; BARTONELLA HENSELAE; BARTONELLA QUINTANA; BARTONELLOSIS; CARRION DISEASE; CAT; CLINICAL TRIAL; DOG; DRUG MECHANISM; EPSILOMETER TEST; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BARTONELLA; BARTONELLA INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

ANIMALIA; BARTONELLA; MAMMALIA; NEGIBACTERIA; PROTEOBACTERIA;

EID: 78650229927     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.133     Document Type: Review

References (137)

1. Anderson BE, Neuman MA: Bartonella spp. as emerging human pathogens. Clin. Microbiol. Rev. 10, 203-219 (1997).
2. Maurin M, Birtles RJ, Raoult D: Current knowledge of Bartonella species. Eur. J. Clin. Microbiol. Infect. Dis. 16, 487-506 (1997).
3. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D: Recommendations for treatment of human infections caused by Bartonella species. Antimicrob. Agents Chemother. 48, 1921-1933 (2004).
4. Jacomo V, Kelly PJ, Raoult D: Natural history of Bartonella infections (an exception to Koch's postulate). Clin. Diagn. Lab. Immunol. 9, 8-18 (2002).
5. Rolain JM, Scola BL, Liang Z, Davoust B, Raoult D: Immunofuorescent detection of intraerythrocytic Bartonella henselae in naturally infected cats. J. Clin. Microbiol. 39, 2978-2980 (2001).
6. Rolain JM, Foucault C, Guieu R, La Scola B, Brouqui P, Raoult D: Bartonella quintana in human erythrocytes. Lancet 360(9328), 226-228 (2002).
7. Carithers HA: Cat-scratch disease: an overview based on a study of 1200 patients. Am. J. Dis. Child. 139, 1124-1133 (1985).
8. Dolan MJ, Wong MT, Regnery RL et al.: Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann. Intern. Med. 118, 331-336 (1993).
9. Windsor JJ: Cat-scratch disease: epidemiology, aetiology and treatment. Br. J. Biomed. Sci. 58(2), 101-110 (2001).
10. Regnery RL, Olson TG, Perkins BA, Bibb W: Serological response to Rochalimaea henselae antigen in suspected cat-scratch disease. Lancet. 339, 1443-1445 (1992).
11. Regnery R, Martin M, Olson J: Naturally occurring 'Rochalimaea henselae' infection in domestic cat. Lancet 29, 340(8818), 557-558 (1992).
12. Breitschwerdt EB, Kordick DL, Malarkey DE, Keene B, Hadfeld TI, Wilson K: Endocarditis in a dog due to infection with a novel Bartonella subspecies. J. Clin. Microbiol. 33(1), 154-160 (1995).
13. Henn JB, Gabriel MW, Kasten RW et al.: Infective endocarditis in a dog and the phylogenetic relationship of the associated 'Bartonella rochalimae' strain with isolates from dogs, gray foxes, and a human. J. Clin. Microbiol. 47(3), 787-790 (2009).
14. Breitschwerdt EB, Maggi RG, Chomel BB, Lappin MR: Bartonellosis: an emerging infectious disease of zoonotic importance to animals and human beings. J. Vet. Emerg Crit. Care. 20(1), 8-30 (2010).
15. Droz S, Chi B, Horn E, Steigerwalt AG, Whitney AM, Brenner DJ: Bartonella koehlerae sp. nov, isolated from cats. J. Clin. Microbiol. 37(4), 1117-1122 (1999).
16. Chomel BB, Boulouis HJ, Maruyama S, Breitschwerdt EB: Bartonella spp. in pets and effect on human health. Emerg. Infect. Dis. 12, 389-394 (2006).
17. Boulouis HJ, Chang CC, Henn JB et al.: Factors associated with the rapid emergence of zoonotic Bartonella infections. Vet. Res. 36, 383-410 (2005).
18. Chomel BB, Kasten RW, Floyd-Hawkins K et al.: Experimental transmission of Bartonella henselae by the cat fea. J. Clin. Microbiol. 34, 1952-1956 (1996).
19. Foil L, Andress E, Freeland RL et al.: Experimental infection of domestic cats with Bartonella henselae by inoculation of Ctenocephalides felis (Siphonaptera: Pulicidae) feces. J. Med. Entomol. 35, 625-628 (1998).
20. Guptill L: Bartonellosis. Vet. Microbiol. 140(3-4), 347-359 (2010).
21. Mikolajczyk MG, O'Reilly KL: Clinical disease in kittens inoculated with a pathogenic strain of Bartonella henselae. Am. J. Vet. Res. 61(4), 375-379 (2000).
22. O'Reilly KL, Bauer RW, Freeland RL et al.: Acute clinical disease in cats following infection with a pathogenic strain of Bartonella henselae (LSU16). Infect. Immun. 67 (6), 3066-3072 (1999).
23. Guptill L, Slater L, Wu CC et al.: Experimental infection of young specific pathogen-free cats with Bartonella henselae. J. Infect. Dis. 176, 206-216 (1997).
24. Kordick DL, Brown TT, Shin K, Breitschwerdt EB: Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats. J. Clin. Microbiol. 37(5), 1536-1547 (1999).
25. Breitschwerdt EB: Bartonellosis: of cats, dogs, mice and men. 15th ACVIM Forum. 505-509 (1997).
26. Chomel BB, Henn JB, Kasten RW et al.: Dogs are more permissive than cats or guinea pigs to experimental infection with a human isolate of Bartonella rochalimae. Vet. Res. 40(4), 27 (2009).
27. Yamamoto K, Chomel BB, Kasten RW et al.: Experimental infection of domestic cats with Bartonella koehlerae and comparison of protein and DNA profles with those of other Bartonella species infecting felines. J. Clin. Microbiol. 40 (2), 466-474 (2002).
28. Kordick DL, Swaminathan B, Greene CE et al.: Bartonella vinsonii subsp. berkhoffi subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii. Int. J. Syst. Bacteriol. 46, 704-709 (1996).
29. Breitschwerdt EB, Atkins CE, Brown TT et al.: Bartonella vinsonii subsp. berkhoffi and related members of the alpha subdivision of the Proteobacteria in dogs with cardiac arrhythmias, endocarditis, or myocarditis. J. Clin. Microbiol. 37(11), 3618-3626 (1999).
30. Chomel BB, MacDonald KA, Kasten RW et al.: Aortic valve endocarditis in a dog due to Bartonella clarridgeiae. J. Clin. Microbiol. 39(10), 3548-3554 (2001).
31. Chomel BB, Wey AC, Kasten RW: Isolation of Bartonella washoensis from a dog with mitral valve endocarditis. J. Clin. Microbiol. 41(11), 5327-5332 (2003).
32. Cross JR, Rossmeisl JH, Maggi RG, Breitschwerdt EB, Duncan RB: Bartonella-associated meningoradiculoneuritis and dermatitis or panniculitis in 3 dogs. J. Vet. Int. Med. 22, 674-678 (2008).
33. Kitchell BE, Fan TM, Kordick D, Breitschwerdt EB, Wollenberg G, Lichtensteiger CA: Peliosis hepatis in a dog infected with Bartonella henselae. J. Am. Vet. Med. Assoc. 216(4), 519-523 (2000).
34. Leibovitz K, Pearce L, Brewer M, Lappin MR: Bartonella species antibodies and DNA in cerebral spinal fuid of cats with central nervous system disease. J. Fel. Med. Surg. 10, 331-337 (2008).
35. MacDonald KA, Chomel BB, Kittleson MD, Kasten RW, Thomas WP, Pesavento P: A prospective study of canine infective endocarditis in northern California (1999-2001): emergence of Bartonella as a prevalent etiologic agent. J. Vet. Int. Med. 18, 56-64 (2004).
36. Mellor PJ, Fetz K, Maggi RG et al.: a1-proteinase inhibitor defciency and Bartonella infection in association with panniculitis, polyarthritis, and meningitis in a dog. J. Vet. Intern. Med. 20(4), 1023-1028 (2006).
37. Morales SC, Breitschwerdt EB, Washabau EJ, Matise I, Maggi RG, Duncan AW: Detection of Bartonella henselae DNA in two dogs with pyogranulomatous lymphadenitis. J. Am. Vet. Med. Assoc. 230(5), 681-685 (2007).
38. Pappalardo BL, Brown T, Gookin J, Morrill CL, Breitschwerdt EB: Granulomatous disease associated with Bartonella infection in 2 dogs. J. Vet. Int. Med. 14(1), 37-42 (2000).
39. Saunders GK, Monroe WE: Systemic granulomatous disease and sialometaplasia in a dog with Bartonella infection. Vet. Pathol. 43, 391-392 (2006).
40. Birtles RJ, Harrison TG, Saunders NA, Molyneux DH: Proposals to unify the genera Grahamella and Bartonella, with descriptions of Bartonella talpae comb. nov., Bartonella peromysci comb. nov., and three new species, Bartonella grahamii sp.nov., Bartonella taylorii sp. nov., and Bartonella doshiae sp. nov. Int. J. Syst. Bacteriol. 45, 1-8 (1995).
41. Bermond D, Heller R, Barrat F et al.: Bartonella birtlesii sp. nov., isolated from small mammals (Apodemus spp.). Int. J. Syst. Evol. Microbiol. 50 Pt 6, 1973-1979 (2000).
42. Kosoy M, Murray M, Gilmore RD Jr, Bai Y, Gage KL: Bartonella strains from ground squirrels are identical to Bartonella washoensis isolated from a human patient. J. Clin. Microbiol. 41(2), 645-650 (2003).
43. Iralu J, Bai Y, Crook L et al.: Rodent-associated Bartonella febrile illness, Southwestern United States. Emerg. Infect. Dis. 12(7), 1081-1086 (2006).
44. Welch DF, Carroll KC, Hofmeister EK et al.: Isolation of a new subsepcies. Bartonella vinsonii subsp. arupensis, from a cattle rancher: identity with isolates found in conjunction with Borrelia burgdorferi and Babesia microti among naturally infected mice. J. Clin. Microbiol. 37(8), 2598-2601 (1999).
45. Jones SL, Maggi R, Shuler J, Alward A, Breitschwerdt EB: Detection of Bartonella henselae in the blood of 2 adult horses. J. Vet. Intern. Med. 22(2), 495-498 (2008).
46. Ye X, Li GW, Yao ML, Luo W, Su LQ: Study on the prevalence and genotypes of Bartonella species in rodent hosts from Fujian coastal regions. Zhonghua Liu Xing Bing Xue Za Zhi 30(10), 989-992 (2009).
47. Cherry NA, Cannedy AL, Maggi RG, Breitschwerdt EB: PCR detection of Bartonella bovis and Bartonella henselae in the blood of beef cattle. Vet. Microbiol. 135(3-4), 308-312 (2009).
48. Maillard R, Riegel P, Barrat F et al.: Bartonella chomelii sp. nov., isolated from French domestic cattle (Bos taurus). Int. J. Syst. Evol. Microbiol. 54, 215-220 (2004).
49. Dehio C, Lanz C, Pohl R et al.: Bartonella schoenbuchii sp. nov., isolated from the blood of wild roe deer. Int. J. Syst. Evol. Microbiol. 51, 1557-1565 (2001).
50. Koehler JE, Tappero JW: Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodefciency virus. Clin. Infect. Dis. 17(4), 612-624 (1993).
51. Ellis BA, Rotz LD, Leake JAD et al.: An outbreak of acute bartonellosis (Oroya fever) in the Urubamba region of Peru, 1998. Am. J. Trop. Med. 61, 344-349 (1999).
52. Alexander B: A review of bartonellosis in Ecuador and Colombia. Am. J. Trop. Med. Hyg. 52, 354-359 (1995).
53. Amano Y, Rumbea J, Knobloch J, Olson J, Kron M: Bartonellosis in Ecuador: serosurvey and current status of cutaneous verrucous disease. Am. J. Trop. Med. Hyg. 57, 174-179 (1997).
54. Maguina Vargas C: Bartonellosis o enfermedad de carrion. Nuevos aspectos de una vieja enfermedad. AFA Editores Importadores, Lima, Peru. 7-195 (1998).
55. Chamberlin J, Laughlin LW, Romero S et al.: Epidemiology of endemic Bartonella bacilliformis: a prospective cohort study in a Peruvian mountain valley community. J. Infect. Dis. 186(7), 983-990 (2002).
56. Kosek M, Lavarello R, Gilman RH et al.: Natural history of infection with Bartonella bacilliformis in a nonendemic population. J. Infect. Dis. 182(3), 865-872 (2000).
57. Ricketts WE: Clinical manifestations of Carrión's disease. Arch. Intern. Med. (Chic). 84(5), 751-781 (1949).
58. Hambuch TM, Handley SA, Ellis B, Chamberlin J, Romero S, Regnery R: Population genetic analysis of Bartonella bacilliformis isolates from areas of peru where Carrion's disease is endemic and epidemic. J. Clin. Microbiol. 42(8), 3675-3680 (2004).
59. Maurin M, Raoult D: Bartonella (Rochalimaea) quintana infections. Clin. Microbiol. Rev. 9, 273-292 (1996).
60. Spach DH, Kanter AS, Dougherty MJ et al.: Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N. Engl. J. Med. 332, 424-428 (1995).
61. Brouqui P, Scola BL, Roux V, Raoult D: Chronic Bartonella quintana bacteremia in homeless patients. N. Engl. J. Med. 340, 184-189 (1999).
62. Foucault C, Barrau K, Brouqui P, Raoult D: Bartonella quintana bacteremia among homeless people. Clin. Infect. Dis. 35, 684-689 (2002).
63. Bouchouicha R, Durand B, Monteil M et al.: Molecular epidemiology of feline and human Bartonella henselae isolates. Emerg. Infect. Dis. 15(5), 813-816 (2009).
64. Chang CC, Chomel BB, Kasten RW, Tappero JW, Sanchez MA, Koehler JE: Molecular epidemiology of Bartonella henselae infection in human immunodefciency virus-infected patients and their cat contacts, using pulsed-feld gel electrophoresis and genotyping. J. Infect. Dis. 186, 1733-1739 (2002).
65. Florin TA, Zaoutis TE, Zaoutis LB: Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics 121, 1413-1425 (2008).
66. Woestyn S, Olive N, Bigaignon G, Avesani V, Michel D: Study of genotypes and virB4 secretion gene of Bartonella henselae strains from patients with clinically defned cat scratch disease. J. Clin. Microbiol. 42(4), 1420-1427 (2004).
67. Margileth AM: Cat scratch disease. Adv. Pediatr. Infect. Dis. 8, 1-21 (1993).
68. Angelakis E, Lepidi H, Canel A et al.: Human case of Bartonella alsatica lymphadenitis. Emerg. Infect. Dis. 14(12), 1951-1953 (2008).
69. Chomel BB, Boulouis HJ, Breitschwerdt EB: Cat scratch disease and other zoonotic Bartonella infections. J. Am. Vet. Med. Assoc. 224(8), 1270-1279 (2004).
70. Kordick DL, Wilson KH: Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients. J. Clin. Microbiol. 33, 3245-3251 (1995).
71. Bass J W, Vincent JM, Person DA: The expanding spectrum of Bartonella infections. II. Cat-scratch disease. Pediatr. Infect. Dis. J. 16, 163-179 (1997).
72. Lamps LW, Scott MA: Cat-scratch disease: historic, clinical, and pathologic perspectives. Am. J. Clin. Pathol. 121(Suppl.), S71-S80 (2004).
73. Koehler JE: Bartonella infections. Adv. Pediatr. Infect. Dis. 11, 1-27 (1996).
74. Perkocha LA, Geaghan SM, Yen BTS et al.: Clinical and pathological features of bacillary peliosis hepatis in association with human immunodefciency virus infection. N. Engl. J. Med. 323, 1581-1586 (1990).
75. Zanzen A, Rolain JM, Hammami N et al.: High prevalence of Bartonella quintana endocarditis in Sfax, Tunisia. Am. J. Trop. Med. Hyg. 72(5), 503-507 (2005).
76. Brouqui P, Raoult D: Endocarditis due to rare and fastidious bacteria. Clin. Microbiol. Rev. 14(1), 177-207 (2001).
77. Fournier PE, Lelievre H, Eykyn SJ et al.: Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine 80, 245-251 (2001).
78. Roux V, Eykyn SJ, Wyllie S, Raoult D: Bartonella vinsonii subsp. berkhoffi as an agent of afebrile blood culture-negative endocarditis in a human. J. Clin. Microbiol. 38, 1698-1700 (2000).
79. Drancourt M, Mainardi JL, Brouqui P et al.: Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N. Engl. J. Med. 332, 419-423 (1995).
80. Raoult D, Fournier PE, Drancourt M et al.: Diagnosis of 22 new cases of Bartonella endo carditis. Ann. Intern. Med. 125, 646-652 (1996).
81. Raoult D, Fournier PE, Vandenesch F et al.: Outcome and treatment of bartonella endocarditis. Arch. Intern. Med. 163, 226-230 (2003).
82. Spach DH, Callis K P, Paauw DS et al.: Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodefciency virus. J. Clin. Microbiol. 31, 692-694 (1993).
83. Spach DH, Kanter AS, Daniels NA et al.: Bartonella (Rochalimaea) species as a cause of apparent, culture-negative' endocarditis. Clin. Infect. Dis. 20, 1044-1047 (1995).
84. Hadfeld TL, Warren R, Kass M, Brun E, Levy C: Endocarditis caused by Rochalimaea henselae. Hum. Pathol. 24, 1140-1141 (1993).
85. Daly JS, Worthington MG, Brenner DJ et al.: Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J. Clin. Microbiol. 31, 872-881 (1993).
86. Raoult D, Roblot F, Rolain JM et al.: First isolation of Bartonella alsatica from a valve of a patient with endocarditis. J. Clin. Microbiol. 44(1), 278-279 (2006).
87. Lin EY, Tsigrelis C, Baddour LM et al.: Candidatus Bartonella mayotimonensis and endocarditis. Emerg. Infect. Dis. 16(3), 500-503 (2010).
88. Kosoy M, Morway C, Sheff KW et al.: Bartonella tamiae sp. nov., a newly recognized pathogen isolated from three human patients from Thailand. J. Clin. Microbiol. 46(2), 772-775 (2008).
89. Eremeeva ME, Gerns HL, Lydy SL et al.: Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species. N. Engl. J. Med. 356(23), 2381-2387 (2007).
90. Maurin M, Gasquet S, Ducco C, Raoult D: MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates. Antimicrob. Agents Chemother. 39l, 2387-2391 (1995).
91. Wolfson C, Branley J, Gottlieb T: The E-test for antimicrobial susceptibility testing of Bartonella henselae. J. Antimicrob. Chemother. (38), 963-968 (1996).
92. Dorbecker C, Sander A, Oberle K, Schulin-Casonato T: In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of E-test and agar dilution. J. Antimicrob. Chemother. 58(4), 784-788 (2006).
93. Pendle S, Ginn A, Iredell J: Antimicrobial susceptibility of Bartonella henselae using Etest methodology. J. Antimicrob. Chemother. 57, 761-763 (2006).
94. Myers WF, Grossman DM, Wisseman CL Jr: Antibiotic susceptibility patterns in Rochalimaea quintana, the agent of trench fever. Antimicrob. Agents Chemother. 25, 690-693 (1984).
95. Ives TJ, Manzewitsch P, Regnery RL, Butts JD, Kebede M: In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofuorescent-antibody ana lysis of infected Vero cell monolayers. Antimicrob. Agents Chemother. 41, 578-582 (1997).
96. Ives TJ, Marston EL, Regnery RL, Butts JD: In vitro susceptibilities of Bartonella and Rickettsia spp. to fuoroquinolone antibiotics as determined by immunofuorescent antibody ana lysis of infected Vero cell monolayers. Int. J. Antimicrob. Agents 18, 217-222 (2001).
97. Ives TJ, Marston EL, Regnery RL, Butts JD, Majerus TC: In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofuorescent antibody analysis of infected Vero cell monolayers. J. Antimicrob. Chemother. 45, 305-310 (2000).
98. Rolain JM, Maurin M, Raoult D: Bactericidal effect of antibiotics on Bartonella and Brucella spp.: clinical implications. J. Antimicrob. Chemother. 46, 811-814 (2000).
99. Musso D, Drancourt M, Raoult D: Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae. J. Antimicrob. Chemother. 36, 101-108 (1995).
100. Fluit AC, Visser MR, Schmitz FJ: Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 14, 836-871 (2001).
101. Saisongkorh W, Robert C, La Scola B et al.: Evidence of transfer by conjugation of type IV secretion system genes between Bartonella species and Rhizobiam radiobacter in amoeba. PLoS One. 13, 5(9), E12666 (2010).
102. Angelakis E, Biswas S, Taylor C: Heterogeneity of susceptibility to fuoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA. J. Antimicrob. Chemother. 61(6), 1252-1255 (2008).
103. Biswas S, Raoult D, Rolain JM: A bioinformatic approach to understanding antibiotic resistance in intracellular bacteria through whole genome analysis. Int. J. Antimicrob. Agents. 32(3), 207-220 (2008).
104. Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF: Gyrase mutations in laboratory-selected, fuoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 40, 1768-1774 (1996).
105. Rodriguez JC, Ruiz M, Climent A, Royo G: In vitro activity of four fuoroquinolones against Mycobacterium tuberculosis. Int. J. Antimicrob. Agents 17, 229-231 (2001).
106. Cambau E, Sougakoff W, Besson M, Truffot-Pernot C, Grosset J, Jarlier V: Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fuoroquinolones during treatment with ofoxacin. J. Infect. Dis. 170, 1351 (1994).
107. Biswas S, Raoult D, Rolain JM: Molecular characterization of resistance to macrolides in Bartonella henselae. Antimicrob. Agents Chemother. 50, 3192-3193 (2006).
108. Angelakis E, Raoult D, Rolain JM: Molecular characterization of resistance to fuoroquinolones in Bartonella henselae and Bartonella quintana. J. Antimicrob. Chemother. 63(6), 1288-1289 (2009).
109. Biswas S, Raoult D, Rolain JM: Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis. J. Antimicrob. Chemother. 59, 1065-1070 (2007).
110. Meghari S, Rolain JM, Grau GE et al.: Anti-angiogenic effect of erythromycin in Bartonella quintana: in vitro model of infection. J. Infect. Dis. 193, 380-386 (2006).
111. Biswas S, Maggi RG, Papich MG, Keil D, Breitschwerdt EB: Comparative activity of pradofoxacin, enrofoxacin, and azithromycin against Bartonella henselae isolates collected from cats and a human. J. Clin. Microbiol. 48(2), 617-618 (2010).
112. Biswas S, Maggi RG, Papich MG, Breitschwerdt EB: Molecular mechanisms of Bartonella henselae resistance to azithromycin, pradofoxacin and enrofoxacin. J. Antimicrob. Chemother. 65(3), 581-582 (2010).
113. Biswas S, Raoult D, Rolain JM: Molecular mechanism of gentamicin resistance in Bartonella henselae. Clin Microb Infect. 15(Suppl. 2) 98-99 (2009).
114. Davies J, Wright G: Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 5(6), 234-240 (1997).
115. Mingeot-Leclercq MP: Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43(4), 727-737 (1999).
116. Pfster P: The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and x-ray crystal structures. ChemBioChem. 4(10), 1078-1088 (2003).
117. Rchet MI: Effect of mutations in the A site of 16S rRNA on aminoglycoside antibiotic-ribosome interaction. J. Mol. Biol. 286(1), 33-43 (1999).
118. Tenover FC: Mechanisms of antimicrobial resistance in bacteria. Am. J. Infect. Control. 34(5 Suppl. 1), S3-S10; discussion S64-S73 (2006).
119. Blondeau JM: Fluoroquinolones: mechanism of action, classifcation, and development of resistance. Surv. Ophthalmol. 49(Suppl. 2), S73-S78 (2004).
120. Hooper DC: Mechanisms of fuoroquinolone resistance. Drug Resist. Updat. 2, 38-55 (1999).
121. Everett MJ, Piddock LJV: Mechanisms of resistance to fuoroquinolones. In: Quinolone Antibacterials. Kuhlmann J, Dahlhoff A, Zeiler HJ (Eds). Springer-Verlag KG, Berlin, Germany 259-297 (1998).
122. Drlica K, Zhao X: DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61, 377-392 (1997).
123. Bagel S, Hullen V, Wiedemann B, Heisig P: Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob. Agents Chemother. 43, 868-875 (1999).
124. Minnick MF, Wilson ZR, Smitherman LS, Samuels DS: gyrA mutations in ciprofoxacin-resistant Bartonella bacilliformis strains obtained in vitro. Antimicrob. Agents Chemother. 47, 383-386 (2003).
125. Tavío MM, Vila J, Ruiz J, Ruiz J, Martín-Sánchez AM, Jiménez de Anta MT: Mechanisms involved in the development of resistance to fuoroquinolones in Escherichia coli isolates. J. Antimicrob. Chemother. 44(6), 735-742 (1999).
126. Biswas S, Raoult D, Rolain JM: Molecular characterisation of resistance to rifampin in Bartonella quintana. Clin. Microbiol. Infect. 15(Suppl. 2), 100-101 (2009).
127. Yam WC, Tam CM, Leung CC: Direct detection of rifampin-resistant Mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing. J. Clin. Microbiol. 42(10), 4438-4443 (2004).
128. Telenti A, Imboden A, Marchesi F et al.: Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341, 647-650 (1993).
129. Ramaswamy S, Musser JM: Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 79, 3-29 (1998).
130. Kordick DL, Papich MG, Breitschwerdt EB: Effcacy of enrofoxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats. Antimicrob. Agents Chemother. 41, 2448-2455 (1997).
131. Breitschwerdt EB, Maggi RG, Cadenas MB, de Paiva Diniz PP: A groundhog, a novel Bartonella sequence, and my father's death. Emerg. Infect. Dis. 15(12), 2080-2086 (2009).
132. Diniz PP, Wood M, Maggi RG, Sontakke S, Stepnik M, Breitschwerdt EB: Co-isolation of Bartonella henselae and Bartonella vinsonii subsp. berkhoffi from blood, joint and subcutaneous seroma fuids from two naturally infected dogs. Vet. Microbiol. 18, 138(3-4), 368-372 (2009).
133. Margileth AM: Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr. Infect. Dis. J. 11, 474-478 (1992).
134. Bass JW, Freitas BC, Freitas AD et al.: Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr. Infect. Dis. J. 17, 447-452 (1998).
135. Bass JW, Vincent JM, Person DA: The expanding spectrum of Bartonella infections. I. Bartonellosis and trench fever. Pediatr. Infect. Dis. J. 16, 2-10 (1997).
136. Foucault C, Raoult D, Brouqui P: Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia. Antimicrob. Agents Chemother. 47, 2204-2207 (2003).
137. Maguina C, Garcia PJ, Gotuzzo E, Cordero L, Spach DH: Bartonellosis (Carrion's disease) in the modern era. Clin. Infect. Dis. 33, 772-779 (2001).